CHRISTOPHER DONNELLY: Open Payments
NPI 1053180836 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 30 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $158 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $260 |
| AstraZeneca Pharmaceuticals LP | 3 | $174 |
| Novo Nordisk Inc | 7 | $143 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Bausch Health US, LLC | 4 | $71 |
| Antares Pharma, Inc. | 2 | $41 |
| Exact Sciences Corporation | 1 | $22 |
| Medtronic, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $15 |
Products named: REPATHA, AIRSUPRA, ZORYVE, VOQUEZNA, Wegovy, APLENZIN, XYOSTED, Rybelsus.
Industry payments across TX — which companies pay providers there.
